清肺化痰方治疗肺炎喘嗽痰热型（社区获得性肺炎）临床疗效观察
|
摘要
目的：观察清肺化痰方治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)与单纯的西医治疗在临床症状、体征、血清C-反应蛋白、血分析及胸片的影响,提出中西医结合优化方案。探讨清肺化痰方在治疗该病的临床价值及推广意义。
方法：将收集符合纳入标准的60例肺炎喘嗽痰热型(社区获得性肺炎)病例随机分成两组,即清肺化痰方组、西药对照组各30例,分别予治疗10天,观察治疗后两组对肺炎喘嗽痰热型(社区获得性肺炎)患者临床症状、体征、C-反应蛋白及实验室和影像学的影响。比较治疗组与对照组的疗效优劣,以客观评价清肺化痰方治疗肺炎喘嗽痰热型(社区获得性肺炎)的临床疗效。
结果：1.治疗组和对照组治疗后发热(包括持续时间、退热时间)；咯痰(包括痰色、痰量、痰质)的改变；咳嗽(包括发作持续时间、咳嗽的剧烈程度)改变和肺部湿罗音分别与治疗前比较,经t检验,P<0.05,差异有显著性,两组治疗后发热(包括的持续时间、退热时间)；咯痰(包括痰色、痰量、痰质)改变等症状经t检验,P<0.05,差异有显著性；治疗后咳嗽(包括发作持续时间、剧烈程度)的改变、肺部湿罗音等症状经t检验,P>0.05,无显著性差异；2.治疗组治疗后血清CRP明显降低,与治疗前比较,经t检验,P<0.05,差异有显著性；对照组治疗后血清CRP与治疗前比较,经t检验,P<0.05,差异有显著性；治疗后两组血清CRP数值同时段比较经t检验,P<0.05,差异有显著性意义；3.治疗组治疗后血分析中白细胞数明显降低,与治疗前比较,经t检验,P<0.05,差异有显著性；对照组治疗后血分析中白细胞数治疗前比较,经t检验,P<0.05,差异有显著性；两组治疗后白细胞数值恢复正常所需的时间经t检验,P<0.05,差异有显著性；4.治疗组治疗后胸片肺部渗出影有所消散,与治疗前比较,经秩和检验,P<0.05,差异有显著性；对照组治疗后胸片肺部渗出影亦有所消散,与治疗前比较,经秩和检验,P<0.05,差异有显著性；但两组治疗后胸片指标经秩和检验,P<0.05,差异有显著性。
结论：1.治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)患者可改善其发热的持续时间、退热时间；咯痰,包括痰色、痰量、痰质；咳嗽的发作持续时间、咳嗽的剧烈程度、肺部湿啰音等症状与体征,且同对照组相比,可明显改善患者的发热、咯痰等主症及兼次症；2.治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)患者可明显降低其血清CRP水平,且C反应蛋白恢复正常所需时间优于单纯西医治疗；3.治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)患者可明显降低血分析中白细胞数水平,且白细胞数水平恢复正常所需时间优于单纯西医治疗；4.治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)患者可明显改善胸片肺部渗出影状况,两组治疗后相比,治疗组有明显优势；
Objective:To observe the influence of Qingfei Huatan decoction for Pneumonia(community acquired pneumonia) patients of the type of TanRe with clinical symptoms and signs score and serum C reaction protein, hemanalysis and lung X-ray, and to suggest prioritization scheme of integration of traditional and western medicine. To explore the clinical treatment efficacy and generalization meaning that the usage of Qingfei Huatan decoction.
Methods:According to the inclusion criteria,60 Pneumonia (community acquired pneumonia) patients of the type of TanRe were selected and randomly divided into the treatment group and the control group, with 30 cases in each group. The treatment group with Qingfei Huatan decoction intergrated Western medicine, while the control group with conventional Western medicine alone, the treatment consisits 7 days. And the two groups of the patients with Pneumonia (community acquired pneumonia) of the type of TanRe symptoms, signs, serum C reaction protein, hemanalysis and lung X-ray are observed. To evaluate objectively the clinical treatment efficacy to comparison with the two groups.
Results:1. The treatment group and the control group after treatment those of clinical symptoms and signs such as persistence time of fever, pyretolysis time, pattern of fever modification;stethocatharsis modification-the colour, quantity, quality; cough modification-persistence time, intensity level; subjective perceptions of the patients; moist rales were significantly improved(p<0.05), and for symptoms and signs such as persistence time of fever, pyretolysis time, pattern of fever modification;stethocatharsis modification-the colour, quantity, quality; subjective perceptions of the patients,the treament group better than the control group(p<0.05), another nrales were no significant differences in the two groups(p>0.05).2. The count of serum C reaction protein in the treatment group after treatment could be declined, the difference was significant(p<0.05), and the conclusion of the control group was the same with the treament group(p<0.05), and the level of CRP of the treament group was lower than the control group(p<0.05).3. The count of WBC in the hemanalysis in the treatment group and the control group after treatment could be declined, the difference was significant(p<0.05), and the level of WBCin the hemanalysis of the treatment group lower than the control group(p<0.05).4. Qingfei Huatan decoction on the lung X-ray was significant impact. The lung X-ray indicatored effusion of two groups increased pre-treatment but significant decreased after treatment, the difference was significant(p<0.05), indicating a significant improvement in lung X-ray, and the two groups of indicators of lung X-ray after treatment showed significant difference(p<0.05).
Conclusion:1.The treatment group treated Pneumonia(community acquired pneumonia) patients of the type of TanRe was more significant improvement the simple western medicine group, those of clinical symptoms and signs such as persistence time of fever, pyretolysis time, pattern of fever modification;stethocatharsis modification-the colour, quantity, quality;cough modification-persistence time, intensity level; subjective perceptions of the patients; moist rales significantly improve the control rate of clinical treatment.2. The treatment group could reduce the count of serum C reaction protein after treatment better than the control group.3. The treatment group could reduce the count of WBC in the hemanalysis better than the control group after treatment;and the time of recovery normal of the hemanalysis was shorted than the control group.4. The treatment group and the control group could be significantly improved in lung X-ray. The treatment group was better than the control group after treatment.
方法：将收集符合纳入标准的60例肺炎喘嗽痰热型(社区获得性肺炎)病例随机分成两组,即清肺化痰方组、西药对照组各30例,分别予治疗10天,观察治疗后两组对肺炎喘嗽痰热型(社区获得性肺炎)患者临床症状、体征、C-反应蛋白及实验室和影像学的影响。比较治疗组与对照组的疗效优劣,以客观评价清肺化痰方治疗肺炎喘嗽痰热型(社区获得性肺炎)的临床疗效。
结果：1.治疗组和对照组治疗后发热(包括持续时间、退热时间)；咯痰(包括痰色、痰量、痰质)的改变；咳嗽(包括发作持续时间、咳嗽的剧烈程度)改变和肺部湿罗音分别与治疗前比较,经t检验,P<0.05,差异有显著性,两组治疗后发热(包括的持续时间、退热时间)；咯痰(包括痰色、痰量、痰质)改变等症状经t检验,P<0.05,差异有显著性；治疗后咳嗽(包括发作持续时间、剧烈程度)的改变、肺部湿罗音等症状经t检验,P>0.05,无显著性差异；2.治疗组治疗后血清CRP明显降低,与治疗前比较,经t检验,P<0.05,差异有显著性；对照组治疗后血清CRP与治疗前比较,经t检验,P<0.05,差异有显著性；治疗后两组血清CRP数值同时段比较经t检验,P<0.05,差异有显著性意义；3.治疗组治疗后血分析中白细胞数明显降低,与治疗前比较,经t检验,P<0.05,差异有显著性；对照组治疗后血分析中白细胞数治疗前比较,经t检验,P<0.05,差异有显著性；两组治疗后白细胞数值恢复正常所需的时间经t检验,P<0.05,差异有显著性；4.治疗组治疗后胸片肺部渗出影有所消散,与治疗前比较,经秩和检验,P<0.05,差异有显著性；对照组治疗后胸片肺部渗出影亦有所消散,与治疗前比较,经秩和检验,P<0.05,差异有显著性；但两组治疗后胸片指标经秩和检验,P<0.05,差异有显著性。
结论：1.治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)患者可改善其发热的持续时间、退热时间；咯痰,包括痰色、痰量、痰质；咳嗽的发作持续时间、咳嗽的剧烈程度、肺部湿啰音等症状与体征,且同对照组相比,可明显改善患者的发热、咯痰等主症及兼次症；2.治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)患者可明显降低其血清CRP水平,且C反应蛋白恢复正常所需时间优于单纯西医治疗；3.治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)患者可明显降低血分析中白细胞数水平,且白细胞数水平恢复正常所需时间优于单纯西医治疗；4.治疗组治疗肺炎喘嗽痰热型(社区获得性肺炎)患者可明显改善胸片肺部渗出影状况,两组治疗后相比,治疗组有明显优势；
Objective:To observe the influence of Qingfei Huatan decoction for Pneumonia(community acquired pneumonia) patients of the type of TanRe with clinical symptoms and signs score and serum C reaction protein, hemanalysis and lung X-ray, and to suggest prioritization scheme of integration of traditional and western medicine. To explore the clinical treatment efficacy and generalization meaning that the usage of Qingfei Huatan decoction.
Methods:According to the inclusion criteria,60 Pneumonia (community acquired pneumonia) patients of the type of TanRe were selected and randomly divided into the treatment group and the control group, with 30 cases in each group. The treatment group with Qingfei Huatan decoction intergrated Western medicine, while the control group with conventional Western medicine alone, the treatment consisits 7 days. And the two groups of the patients with Pneumonia (community acquired pneumonia) of the type of TanRe symptoms, signs, serum C reaction protein, hemanalysis and lung X-ray are observed. To evaluate objectively the clinical treatment efficacy to comparison with the two groups.
Results:1. The treatment group and the control group after treatment those of clinical symptoms and signs such as persistence time of fever, pyretolysis time, pattern of fever modification;stethocatharsis modification-the colour, quantity, quality; cough modification-persistence time, intensity level; subjective perceptions of the patients; moist rales were significantly improved(p<0.05), and for symptoms and signs such as persistence time of fever, pyretolysis time, pattern of fever modification;stethocatharsis modification-the colour, quantity, quality; subjective perceptions of the patients,the treament group better than the control group(p<0.05), another nrales were no significant differences in the two groups(p>0.05).2. The count of serum C reaction protein in the treatment group after treatment could be declined, the difference was significant(p<0.05), and the conclusion of the control group was the same with the treament group(p<0.05), and the level of CRP of the treament group was lower than the control group(p<0.05).3. The count of WBC in the hemanalysis in the treatment group and the control group after treatment could be declined, the difference was significant(p<0.05), and the level of WBCin the hemanalysis of the treatment group lower than the control group(p<0.05).4. Qingfei Huatan decoction on the lung X-ray was significant impact. The lung X-ray indicatored effusion of two groups increased pre-treatment but significant decreased after treatment, the difference was significant(p<0.05), indicating a significant improvement in lung X-ray, and the two groups of indicators of lung X-ray after treatment showed significant difference(p<0.05).
Conclusion:1.The treatment group treated Pneumonia(community acquired pneumonia) patients of the type of TanRe was more significant improvement the simple western medicine group, those of clinical symptoms and signs such as persistence time of fever, pyretolysis time, pattern of fever modification;stethocatharsis modification-the colour, quantity, quality;cough modification-persistence time, intensity level; subjective perceptions of the patients; moist rales significantly improve the control rate of clinical treatment.2. The treatment group could reduce the count of serum C reaction protein after treatment better than the control group.3. The treatment group could reduce the count of WBC in the hemanalysis better than the control group after treatment;and the time of recovery normal of the hemanalysis was shorted than the control group.4. The treatment group and the control group could be significantly improved in lung X-ray. The treatment group was better than the control group after treatment.
引文
[1]周仲瑛,中医内科学,北京：中国中医药出版社,2004,1(1)：71-81
[2]郭霭春,黄帝内经素问校注,北京：人民卫生出版社,1992,2(6)：428-429
[3]陈亦人,伤寒论译释,上海：上海科学技术出版社,1992,3(7)：313-456
[4]林培政,温病学,北京：中国中医药出版社,2004,7(5)：112-123
[5]王孟英,温热经纬,北京：人民卫生出版社,2005,6(8)：114-114
[6]裘沛然,伤寒温病论争中的若干问题,北京中医学院学报,1993；(4)：2-5
[7]郭辉雄,六经是寒温统一的基础,北京中医学院学报,1993；(4)：77
[8]邓铁涛,外感病辩证统一小议,北京中医学院学报,1993；(3)：6-7
[9]万友生,论热病的寒温统一和内外统一,中国医药学报,1996；(1)：10-13
[10]肖德馨,六经辩证纲要,北京中医学院学报,1991；(3)：1-8
[11]董建华,杜怀堂,周平安等,急性热病临床研究的初步设想,中医杂志,1995；(1)：62-65
[12]吴银银,沈庆法,中医外感热病学,上海：上海学术出版社,1991；(3)：39-39
[13]王海明,何建平,张志芬等,外感热病辩证论治规律的研究,贵阳中医学院学报,1999；(2)：7-9
[14]石恩权,邹克扬,黄琴等,外感热病“五定”辩证刍议,贵阳中医学院学报,1987；(1)： 8-10
[15]魏喜保,艾利民,风温病126例临床分析,湖北中医杂志,1994；(6)：16-18
[16]王成祥,辩证老年风温肺热55例,中国中医急症,1992；1(1),；33-36
[17]金妙文,汪红,大叶性肺炎的分型辩治,辽宁中医杂志,2000；27(8)；350-351
[18]蒲辅周,李德珍,杨铭等,辩治小儿腺病毒肺炎经验介绍,新中医,2003；35(2)：7-9
[19]王淑梅,中医治疗老年性肺部感染76例,四川中医,2000；18(9)：29
[20]梅晓萍,辛凉透泄法治疗风温肺热35例疗效观察,新中医,2007；6(39)：6
[21]彭青鹤,克咳2号治疗痰热蕴肺证193例,新中医,2008；8(40)：8
[22]王伟,痰热清联合头孢曲松钠治疗急性肺炎43例,2007；6(4)：7
[23]徐小明,黛芩化痰丸对痰热蕴肺证的临床及实验研究,南京中医大学学报,2000；11(16)：6
[24]赵小刚,肺炎汤治疗肺炎链球菌肺炎痰热蕴肺型51例,新中医,2001；12(16)：5
[25]梁直英,孙志佳,刘晓红等人,千金苇茎汤加味治疗肺部感染129例临床观察,2000；11(13)：6
[26]刘兰林,倪媛媛,龙子江等,升清降浊活血方治疗温病肺系发热的作用机制研究,安徽中医学院学报,2006；25(5)：32-35
[27]周珂,丁邦晗,马智等,清肺消炎饮的药效学实验研究,辽宁中医学报,1999；1(3)：175-177
[28]赵岩松,杨进,龚婕宁,麻杏石甘汤,清燥救肺汤对小鼠病毒性肺炎作用机理的研究,江苏中医药,2007；39(11)：81-83
[29]张薇,卢芳国,何迎春等,麻杏石甘汤体外抗A型流感病毒作用的实验研究,实用预防医学,2007；14(5)：1351-1353
[30]顾风琴,刘宗莲,邹金盘等,咳喘1号冲剂治疗痰热咳喘的研究,光明中医,1998；13(74)：45-46
[31]孟明,陈冬志等痰热清注射液对流感病毒感染小鼠免疫功能的影响,河北大学学报,2006；26(5)：529-535
[32]欧敏,杜怀棠,清肺饮对风温肺热患者NK、IFN、1-2的调节作用,海军总医院学报,2001；14(4)：231-231
[33]刘兰林、王翼洲,升清降浊活血法治疗温病肺系发热的临床研究,北京中医药大学学报,2007；14(1)：28-30
[34]贺晓红,中医结合治疗小儿肺炎56例临床疗效观察,现代临床学,2005；31(5)：327-327
[35]刘建博,孙志佳,张伟,痰热清注射液治疗社区获得性肺炎50例疗效观察,新中医,2006；38(3)：27-29
[36]杨进,温病学,北京：人民卫生出版社,2004,8(1)：82-85
[37]王吉耀,内科学,北京：人民卫生出版社,2005,8(1)：73-75
[38]成人社区获得性肺炎诊断治疗指南2007
[39]刘又宁,陈民均等,中国城市成人获得性肺炎665例病原学多中心调查,中国结核和呼吸杂志,2006；29：3-8
[40]zhao X. Drlica K. Restricting the selection of antibiotic-resistant mutants:a general strategy derived from fluoroquinolones studies Clin infect Dis,2001;33(suppl):S147-S156
[41]Drlica K.A strategy for fighting antibiotic resistance.ASM news,2001; 67:27-33
[42]Butler JC. Freiman RF, Campbell JF, et al. Polysaccharide pneumoncoccal vaccine JAMA,1993; 270:1826-1831.
[43]Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide Vaccine in older adults.New Engl Jmed,2003; 348:1747-1755.
[44]Mandell LA, Bartlett JG, Dowell SF, et al, Update ofpractice guidelines for the management of community-acqiured pneumonia in immunocompetent adults. Clin Infect Dis,2003; 37:1405-1433
[45]British Thoracic Society standards of Care Committee. BTS Guidelines for the Management of Commmunity Acquired Pneumonia in Adults. Thorax,2001; 56Suppl4;IV1-IV6
[46]曾伟刚,郭志远.从瘀论治久咳的经验(J).江苏中医2001；22(12)：12
[47]曾氏(曾凡鹏、王京京、孙晓菊,喘通方治疗慢性阻塞性肺疾病并肺部感染46例临床疗效观察(J),中国药师,2004；7(6)：453-454
[48]荆小莉,王东平,刘建博等,加味千金苇茎汤治疗慢性肺源性心脏病加重期并肺部感染及其对内皮细胞保护作用的研究(J).中国中西医结合急救杂志,2005；12(3)：146-148.
[49]美国感染病学会／美国胸科学会Clinical Infectious Diseases 2007;44:S27-S72
[50]杜勤,叶木荣等,青天葵镇咳、平喘药理作用研究,广州中医药大学学报,2006；23(2)： 12-13
[51]黄兆胜,中药学[M].北京：人民卫生出版社,2002：5(8)：333-358
[52]吕元,朱汉民,沈霞,等译Thomas L,Clinnical laboratory,diagnostics use and assessment of cilnical laboratory results,上海：上海科学技术出版社,2004：677-682
[53]陆晶晶,C反应蛋白的检测及临床意义,临床肺科杂志,2009；12(14)：1653
[54]姚光,新生儿感染中CRP的检测价值,现代医药卫生,2005；21(3)：279
[55]申罗英,老年人感染性疾病C反应蛋白检测意义,浙江中西医结合杂志,2005；15(2) ：94
[56]马春华,董碧容,刘文,C反应蛋白在预测老年院内呼吸道感染中的意义探讨,四川医学,2005；24：405-406
[57]戴万亨,诊断学基础,北京：中国中医药出版社,2003;5(8)：224-225
[58]何礼赞,社区获得性肺炎诊治指南评价及有关问题,中华结核和呼吸杂志,2006；10：27
[59]liu K, Ca talfam oM, LiY, et al. IL-15minicsT cell re-ceptor crosslinking in the induction of cellular pmliferation,gene expression, and cytotoxicity in CD8 memory T cells. Proc Natl Acad sci USA,2002;99:6192-6197
[60]Barnes PJ. Effect of nedocromil sodium or platet-activating factorinduced airway responses. J Allergy Clin Immunol,1993;92:187
[61]王蕾珍,宋兆仪,甘草药理作用的研究.中国中药出版社[J].1997;22(Ⅰ)：50-51
[62]郑莜臾,中药新药临床研究指导原则,北京：中国医药科技出版社,2002,1(1),11
[63]谭延华,刘爱芳,王新英等,黄芩甙和芸香甙对氧自由基的清除作用[J].西安医科大学学报,1997：18(L)：41-43
[64]侯艳宁,朱秀媛,程桂芳等,黄芩甙的抗炎机理[J],药学学报,2000;35(3)：161-164
[2]郭霭春,黄帝内经素问校注,北京：人民卫生出版社,1992,2(6)：428-429
[3]陈亦人,伤寒论译释,上海：上海科学技术出版社,1992,3(7)：313-456
[4]林培政,温病学,北京：中国中医药出版社,2004,7(5)：112-123
[5]王孟英,温热经纬,北京：人民卫生出版社,2005,6(8)：114-114
[6]裘沛然,伤寒温病论争中的若干问题,北京中医学院学报,1993；(4)：2-5
[7]郭辉雄,六经是寒温统一的基础,北京中医学院学报,1993；(4)：77
[8]邓铁涛,外感病辩证统一小议,北京中医学院学报,1993；(3)：6-7
[9]万友生,论热病的寒温统一和内外统一,中国医药学报,1996；(1)：10-13
[10]肖德馨,六经辩证纲要,北京中医学院学报,1991；(3)：1-8
[11]董建华,杜怀堂,周平安等,急性热病临床研究的初步设想,中医杂志,1995；(1)：62-65
[12]吴银银,沈庆法,中医外感热病学,上海：上海学术出版社,1991；(3)：39-39
[13]王海明,何建平,张志芬等,外感热病辩证论治规律的研究,贵阳中医学院学报,1999；(2)：7-9
[14]石恩权,邹克扬,黄琴等,外感热病“五定”辩证刍议,贵阳中医学院学报,1987；(1)： 8-10
[15]魏喜保,艾利民,风温病126例临床分析,湖北中医杂志,1994；(6)：16-18
[16]王成祥,辩证老年风温肺热55例,中国中医急症,1992；1(1),；33-36
[17]金妙文,汪红,大叶性肺炎的分型辩治,辽宁中医杂志,2000；27(8)；350-351
[18]蒲辅周,李德珍,杨铭等,辩治小儿腺病毒肺炎经验介绍,新中医,2003；35(2)：7-9
[19]王淑梅,中医治疗老年性肺部感染76例,四川中医,2000；18(9)：29
[20]梅晓萍,辛凉透泄法治疗风温肺热35例疗效观察,新中医,2007；6(39)：6
[21]彭青鹤,克咳2号治疗痰热蕴肺证193例,新中医,2008；8(40)：8
[22]王伟,痰热清联合头孢曲松钠治疗急性肺炎43例,2007；6(4)：7
[23]徐小明,黛芩化痰丸对痰热蕴肺证的临床及实验研究,南京中医大学学报,2000；11(16)：6
[24]赵小刚,肺炎汤治疗肺炎链球菌肺炎痰热蕴肺型51例,新中医,2001；12(16)：5
[25]梁直英,孙志佳,刘晓红等人,千金苇茎汤加味治疗肺部感染129例临床观察,2000；11(13)：6
[26]刘兰林,倪媛媛,龙子江等,升清降浊活血方治疗温病肺系发热的作用机制研究,安徽中医学院学报,2006；25(5)：32-35
[27]周珂,丁邦晗,马智等,清肺消炎饮的药效学实验研究,辽宁中医学报,1999；1(3)：175-177
[28]赵岩松,杨进,龚婕宁,麻杏石甘汤,清燥救肺汤对小鼠病毒性肺炎作用机理的研究,江苏中医药,2007；39(11)：81-83
[29]张薇,卢芳国,何迎春等,麻杏石甘汤体外抗A型流感病毒作用的实验研究,实用预防医学,2007；14(5)：1351-1353
[30]顾风琴,刘宗莲,邹金盘等,咳喘1号冲剂治疗痰热咳喘的研究,光明中医,1998；13(74)：45-46
[31]孟明,陈冬志等痰热清注射液对流感病毒感染小鼠免疫功能的影响,河北大学学报,2006；26(5)：529-535
[32]欧敏,杜怀棠,清肺饮对风温肺热患者NK、IFN、1-2的调节作用,海军总医院学报,2001；14(4)：231-231
[33]刘兰林、王翼洲,升清降浊活血法治疗温病肺系发热的临床研究,北京中医药大学学报,2007；14(1)：28-30
[34]贺晓红,中医结合治疗小儿肺炎56例临床疗效观察,现代临床学,2005；31(5)：327-327
[35]刘建博,孙志佳,张伟,痰热清注射液治疗社区获得性肺炎50例疗效观察,新中医,2006；38(3)：27-29
[36]杨进,温病学,北京：人民卫生出版社,2004,8(1)：82-85
[37]王吉耀,内科学,北京：人民卫生出版社,2005,8(1)：73-75
[38]成人社区获得性肺炎诊断治疗指南2007
[39]刘又宁,陈民均等,中国城市成人获得性肺炎665例病原学多中心调查,中国结核和呼吸杂志,2006；29：3-8
[40]zhao X. Drlica K. Restricting the selection of antibiotic-resistant mutants:a general strategy derived from fluoroquinolones studies Clin infect Dis,2001;33(suppl):S147-S156
[41]Drlica K.A strategy for fighting antibiotic resistance.ASM news,2001; 67:27-33
[42]Butler JC. Freiman RF, Campbell JF, et al. Polysaccharide pneumoncoccal vaccine JAMA,1993; 270:1826-1831.
[43]Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide Vaccine in older adults.New Engl Jmed,2003; 348:1747-1755.
[44]Mandell LA, Bartlett JG, Dowell SF, et al, Update ofpractice guidelines for the management of community-acqiured pneumonia in immunocompetent adults. Clin Infect Dis,2003; 37:1405-1433
[45]British Thoracic Society standards of Care Committee. BTS Guidelines for the Management of Commmunity Acquired Pneumonia in Adults. Thorax,2001; 56Suppl4;IV1-IV6
[46]曾伟刚,郭志远.从瘀论治久咳的经验(J).江苏中医2001；22(12)：12
[47]曾氏(曾凡鹏、王京京、孙晓菊,喘通方治疗慢性阻塞性肺疾病并肺部感染46例临床疗效观察(J),中国药师,2004；7(6)：453-454
[48]荆小莉,王东平,刘建博等,加味千金苇茎汤治疗慢性肺源性心脏病加重期并肺部感染及其对内皮细胞保护作用的研究(J).中国中西医结合急救杂志,2005；12(3)：146-148.
[49]美国感染病学会／美国胸科学会Clinical Infectious Diseases 2007;44:S27-S72
[50]杜勤,叶木荣等,青天葵镇咳、平喘药理作用研究,广州中医药大学学报,2006；23(2)： 12-13
[51]黄兆胜,中药学[M].北京：人民卫生出版社,2002：5(8)：333-358
[52]吕元,朱汉民,沈霞,等译Thomas L,Clinnical laboratory,diagnostics use and assessment of cilnical laboratory results,上海：上海科学技术出版社,2004：677-682
[53]陆晶晶,C反应蛋白的检测及临床意义,临床肺科杂志,2009；12(14)：1653
[54]姚光,新生儿感染中CRP的检测价值,现代医药卫生,2005；21(3)：279
[55]申罗英,老年人感染性疾病C反应蛋白检测意义,浙江中西医结合杂志,2005；15(2) ：94
[56]马春华,董碧容,刘文,C反应蛋白在预测老年院内呼吸道感染中的意义探讨,四川医学,2005；24：405-406
[57]戴万亨,诊断学基础,北京：中国中医药出版社,2003;5(8)：224-225
[58]何礼赞,社区获得性肺炎诊治指南评价及有关问题,中华结核和呼吸杂志,2006；10：27
[59]liu K, Ca talfam oM, LiY, et al. IL-15minicsT cell re-ceptor crosslinking in the induction of cellular pmliferation,gene expression, and cytotoxicity in CD8 memory T cells. Proc Natl Acad sci USA,2002;99:6192-6197
[60]Barnes PJ. Effect of nedocromil sodium or platet-activating factorinduced airway responses. J Allergy Clin Immunol,1993;92:187
[61]王蕾珍,宋兆仪,甘草药理作用的研究.中国中药出版社[J].1997;22(Ⅰ)：50-51
[62]郑莜臾,中药新药临床研究指导原则,北京：中国医药科技出版社,2002,1(1),11
[63]谭延华,刘爱芳,王新英等,黄芩甙和芸香甙对氧自由基的清除作用[J].西安医科大学学报,1997：18(L)：41-43
[64]侯艳宁,朱秀媛,程桂芳等,黄芩甙的抗炎机理[J],药学学报,2000;35(3)：161-164